CLVLF Stock UPDATES Clinuvel Pharm Ords (CLVLF) 4.3500 09/22/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Clinuvel Pharm Ords (CLVLF) 4.3500 $CLVLF

Retrophin plans to buy remaining shares in Clinuvel Pharmaceuticals in all cash offer
M2 - Mon Jul 28, 6:13AM CDT
Pharmaceutical company Retrophin (NasdaqGM:RTRX) on Sunday announced its proposal to acquire all of the remaining shares of Clinuvel Pharmaceuticals (ASX:CUV.AX).

Retrophin Proposes Acquisition of Clinuvel Pharmaceuticals
Business Wire - Sun Jul 27, 10:47PM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced that on July 17, 2014 it submitted a proposal to the Board of Directors of Clinuvel Pharmaceuticals Ltd (ASX:CUV) to acquire by scheme of arrangement all of the shares of Clinuvel stock that Retrophin does not own for (1) 0.175 Retrophin shares per Clinuvel share, or (2) A$2.17 per share in cash. Retrophin currently owns approximately 4.88% of Clinuvel shares.

Actinic Keratosis - Pipeline Review, H2 2012
M2 - Fri Aug 02, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s2gp3d/actinic_keratosis) has announced the addition of the "Actinic Keratosis - Pipeline Review, H2 2012" report to their offering. This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for actinic keratosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for actinic keratosis. The information is built using data and information sourced from proprietary databases, company/university websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for actinic keratosis. - A review of the actinic keratosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the actinic keratosis pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for actinic keratosis. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding actinic keratosis pipeline depth and focus of Indication therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage Actinic Keratosis Overview Therapeutics Development An Overview of Pipeline Products for Actinic Keratosis Companies Involved in Actinic Keratosis Therapeutics Development Actinic Keratosis - Therapeutics Assessment Drug Profiles Featured News & Press Releases Appendix Companies Mentioned: - Almirall, S.A - Birken GmbH - Celtic Pharmaceutical Holdings L.P - Clinuvel Pharmaceuticals Limited - FunZyme BioTechnologies S.A - GliaMed, Inc - Meda AB - MediQuest Therapeutics, Inc - Moberg Derma AB - NexMed, Inc - Quest PharmaTech Inc - Telormedix SA For more information visit http://www.researchandmarkets.com/research/s2..._keratosis

Vitiligo - Pipeline Review, H1 2013
M2 - Mon Jun 17, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w6wkh6/vitiligo) has announced the addition of the "Vitiligo - Pipeline Review, H1 2013" report to their offering. "Vitiligo - Pipeline Review, H2 2013", provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vitiligo. Scope - A snapshot of the global therapeutic scenario for Vitiligo. - A review of the Vitiligo products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Vitiligo pipeline on th

SurModics Signs License Agreement with Clinuvel Pharmaceuticals
M2 - Sun Jun 16, 7:09AM CDT
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 117

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Ukraine's Satellite: A New Era of Sovereignty

Updated Category News Views 0

Ukraine's Bold Satellite Leap Alright, folks! Ukraine’s got a satellite cruising in orbit, and let me tell you, this ain't just some vanity space flight—it’s a downright pivotal shift in their communications game. Been a rough road to this milestone, but now we're seeing them break free from relying on foreign infrastructure for their satellite needs. What this...

Continue Reading
Thermal Barrier Coatings Growth Fuels Industry Shifts

Updated Category News Views 20

The Heat Is On: Thermal Barrier Coatings Surge The market for thermal barrier coatings is heating up like a Phoenix summer, slated to spike from $1.26 billion in 2026 to $1.55 billion by 2031, riding a tidy 4.19% CAGR. Aerospace engines and gas turbines—these hardcore markets are fueled by rising demand as engineers chase higher efficiency and better heat resistance....

Continue Reading
New Navy Contract Boosts X-Bow's Defense Portfolio

Updated Category News Views 27

Will X-Bow's CHAOS contract shake up defense? Ever get the feeling you're watching a scrappy upstart quietly transform an industry? That's the buzz around X-Bow Systems Inc (X-Bow®) as they announce a partnership with CoAspire for the U.S. Navy's CHAOS program. This ain't just another contract; it's a cornerstone moment for them. So, what's fueling the excitement?...

Continue Reading
Globe Life Faces 8% Stock Dip Amidst Legal Scrutiny

Updated Category News Views 120

Trouble Brews for Globe Life Investors Brace yourselves, folks. Globe Life Inc. (NYSE: GL) has found itself slap-bang in the middle of a potentially messy legal quagmire. The $7 million in excess Medicare Supplement claims that popped up due to a snail-like processing delay by the Centers for Medicare & Medicaid Services (CMS) have sent investors scrambling. And oh boy,...

Continue Reading
XCMG Lends Heavy Equipment to Nairobi Rescue Effort

Updated Category News Views 35

When Buildings Fall and Heavy Equipment Matters Buildings aren't supposed to just topple over. It's not some new trend I missed, but when it does happen, you've got a crisis – and that's exactly what unfolded in Nairobi on October 23 when an 18-story tower gave out, crashing down into chaos in the Eastleigh neighborhood. From Ground Zero to Immediate Response Imagine...

Continue Reading
Infotech's 2027 Trends: AI Reshapes Strategy & Risk

Updated Category News Views 22

AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...

Continue Reading
Landis+Gyr's Big Contract Victory: A Game Changer?

Updated Category News Views 87

Diving into Landis+Gyr's Major Utility Win When news hits about a deal secured by Landis+Gyr Group AG, it rings a few bells across the utility landscape. These folks have brewed up a storm with a fresh contract that slots into their rapidly expanding portfolio of grid-savvy products. So, what’s the fuss about this latest agreement? A Groundbreaking Contract Now, this...

Continue Reading
Exploring Family, Faith, and Forgiveness in New Book

Updated Category News Views 134

Diving into the Depths of Faith and Forgiveness T.L. Dennis ain't just spinning a yarn about his childhood in "A Conversation with a Dead Father". This is a deep dive into the gritty realities of his relationship with his old man, seasoned with the salt of personal struggles and spiritual redemption. The pages of this book open at the one place none of us look for good...

Continue Reading
Encompass Health Eyes Houston Growth with New Hospital

Updated Category News Views 217

Fort Bend County: The Next Step in Encompass Health's Journey Kicking off with some Texas flair, Encompass Health is making notable moves in Fort Bend County, venturing to boost its presence in the greater Houston area. It's no surprise given that this neck of the woods is seeing quite the growth spurt lately. Encompass Health, no stranger to living large, is charting new...

Continue Reading

Top 5 Most Recently Viewed Articles

UniCredit and Google Cloud Join Forces for Digital Evolution

Updated Category News Views 323

UniCredit's Strategic Alliance with Google Cloud The recent partnership between UniCredit and Google Cloud is set to pave the way for significant advancements in the banking industry. This strategic agreement aims to modernize UniCredit's operations, enhancing the bank's digital infrastructure and service offerings. By leveraging Google Cloud's innovative technologies,...

Continue Reading
Mohr Capital Expands Portfolio with Major Real Estate Deal

Updated Category News Views 190

Mohr Capital Makes Significant Acquisition In a strategic move, Mohr Capital, a well-regarded real estate investment firm based in Dallas, has successfully acquired two industrial properties through an 18-year sale leaseback transaction. This acquisition is a testament to their ongoing commitment to expanding their investment portfolio with high-quality assets. Details of...

Continue Reading
Understanding Market Trends in Corning's Options Trading

Updated Category News Views 162

Bearish Sentiment Among Investors Recently, there has been noticeable bearish sentiment among large investors in Corning. The market dynamics reflect a cautious approach towards this stock as traders navigate uncertain economic conditions. Analysis of Options Trading Activity When examining the options trading history for Corning (NYSE: GLW), a total of 29 trades have...

Continue Reading
NanOlogy Announces David J. Arthur as New CEO to Lead Strategy

Updated Category News Views 111

NanOlogy Appoints David J. Arthur as Chief Executive Officer NanOlogy, LLC, a company focused on advancing clinical-stage oncology, has announced the appointment of David J. Arthur as its new Chief Executive Officer. This significant move is expected to enhance NanOlogy's progression in the development of its Large Surface Area Microparticle (LSAM) drug portfolio,...

Continue Reading
Engaging Investors: Sapience Therapeutics at Needham Forum

Updated Category News Views 65

Sapience Therapeutics Prepares for Annual Investor Forum Sapience Therapeutics, Inc., a clinical-stage biotechnology firm, is excited to announce its engagement at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum. This prestigious event will take place soon, providing a platform for the company to connect with investors and share its innovative...

Continue Reading